FIELD: medicine, oncology, pharmacy.
SUBSTANCE: invention proposes using malachite green in form of tetramethyldiaminotriphenylcarbinol anhydrooxalate [(C23H25N2) x (C2HO4)]2 x C2H2O4 of the structural formula (I): 
as an agent for treatment of malignant neoplasms in the dosing from 1 mg to 2 g. Proposed agent shows the broad spectrum of its curative effect with respect to different oncological diseases: carcinoma, adenocarcinoma, sarcoma, melanoma, glyoblastoma, hepatoma, lymphoma. This treatment provides both disappearance of tumor in kidney, bladder, brain, liver and elimination of metastasis.
EFFECT: valuable medicinal properties and enhanced effectiveness of agent.
7 cl, 18 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF NAPHTHALENE DERIVATIVE AS ONCOLOGICAL DISEASE TREATMENT MEDICINE | 2007 |
|
RU2349311C1 |
| APPLICATION OF LIQUID CRYSTALS AS MEDICAL PRODUCTS | 2008 |
|
RU2385153C1 |
| APPLICATION OF RHODAMINE 6G AS MEDICATION FOR TREATMENT OF MALIGNANT NEOPLASMS AND AMYLOIDOSES | 2007 |
|
RU2354369C2 |
| APPLICATION OF ORGANIC DYES AS MEANS FOR TREATMENT OF ONCOLOGICAL DISEASES | 2007 |
|
RU2354384C1 |
| APPLICATION OF FUNGICIDE AS AGENT FOR TREATING ONCOLOGIC DISEASES | 2007 |
|
RU2381027C2 |
| MEDICINAL AGENT FOR ONCOTHERAPY | 2008 |
|
RU2360686C1 |
| MEDICAL PRODUCT FOR TREATMENT OF ONCOLOGIC DISEASES | 2008 |
|
RU2361587C1 |
| MEDICINAL AGENT | 2004 |
|
RU2257200C1 |
| PHARMACEUTICAL AGENT | 2006 |
|
RU2308270C1 |
| DRUG | 2005 |
|
RU2320333C2 |
